The clinical role of perfusion-weighted MRI (PWI) in head and neck squamous cell carcinoma (HNSCC) remains to be defined. The aim of this study was to provide evidence-based recommendations for the use of PWI sequence in HNSCC with regard to clinical indications and acquisition parameters.
Clinical indications and acquisition protocol for the use of dynamic contrast-enhanced MRI in head and neck cancer squamous cell carcinoma: recommendations from an expert panel / Romeo, Valeria; Stanzione, Arnaldo; Ugga, Lorenzo; Cuocolo, Renato; Cocozza, Sirio; Quarantelli, Mario; Chawla, Sanjeev; Farina, Davide; Golay, Xavier; Parker, Geoff; Shukla-Dave, Amita; Thoeny, Harriet; Vidiri, Antonello; Brunetti, Arturo; Surlan-Popovic, Katarina; Bisdas, Sotirios. - In: INSIGHTS INTO IMAGING. - ISSN 1869-4101. - 13:1(2022), p. 198. [10.1186/s13244-022-01317-1]
Clinical indications and acquisition protocol for the use of dynamic contrast-enhanced MRI in head and neck cancer squamous cell carcinoma: recommendations from an expert panel
Romeo, Valeria;Stanzione, Arnaldo;Ugga, Lorenzo;Cuocolo, Renato;Cocozza, Sirio;Brunetti, Arturo;
2022
Abstract
The clinical role of perfusion-weighted MRI (PWI) in head and neck squamous cell carcinoma (HNSCC) remains to be defined. The aim of this study was to provide evidence-based recommendations for the use of PWI sequence in HNSCC with regard to clinical indications and acquisition parameters.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
